Marie Arsenian-Henriksson

Marie Arsenian-Henriksson is a Professor of Molecular Tumor Biology and Academic Vice President for Research at Karolinska Institutet. She holds affiliations with the Department of Microbiology, Tumor and Cell Biology and leads the Neuroblastoma research group. Her academic roles include past leadership as Head of the Department (2006-2016) and current roles in university governance.

Her research focuses on MYC gene regulation, particularly in neuroblastoma and other cancers. Key areas include MYCN-driven oncogenesis, differentiation therapies, and tumor metabolism. She explores molecular mechanisms of cancer progression using models like patient-derived xenografts and advanced imaging techniques.

Her work spans translational research, including grants from the Swedish Research Council, Knut and Alice Wallenberg Foundation, and childhood cancer foundations. Collaborations with groups like the David Lane lab (p53 biology) and Michael Landreh (protein interactions) enhance interdisciplinary efforts.

Publications highlight discoveries in MYCN-driven metabolic vulnerabilities, p53 regulation, and laminin roles in metastasis. Her lab develops novel imaging methods and targets therapeutic strategies for high-risk neuroblastoma.